ORIGINAL
Diferencias de género en el uso de marcadores tumorales
Gender differences in the use of tumour markers
E.E. Moreno-Campoya,b,
, F.J. Mérida-De la Torrec, F. Martos-Crespod, M. Plebanie
Autor para correspondencia
a Unidad de Farmacia, Área de Gestión Sanitaria Serranía de Málaga, Málaga, España
b Universidad de Málaga, Málaga, España
c Laboratorio Clínico, Área de Gestión Sanitaria Serranía de Málaga, Málaga, España
d Departamento de Farmacología, Facultad de Medicina, Universidad de Málaga, Málaga, España
e Laboratorio de Medicina, Hospital de Padua, Padua, Italia
Leído
5048
Vecesse ha leído el artículo
1117
Total PDF
3931
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 15 | 3 | 18 |
| 2025 11 | 46 | 20 | 66 |
| 2025 10 | 49 | 11 | 60 |
| 2025 9 | 51 | 23 | 74 |
| 2025 8 | 55 | 6 | 61 |
| 2025 7 | 59 | 9 | 68 |
| 2025 6 | 48 | 3 | 51 |
| 2025 5 | 68 | 13 | 81 |
| 2025 4 | 74 | 3 | 77 |
| 2025 3 | 63 | 4 | 67 |
| 2025 2 | 89 | 14 | 103 |
| 2025 1 | 58 | 5 | 63 |
| 2024 12 | 27 | 7 | 34 |
| 2024 11 | 17 | 3 | 20 |
| 2024 10 | 14 | 4 | 18 |
| 2024 9 | 29 | 10 | 39 |
| 2024 8 | 34 | 5 | 39 |
| 2024 7 | 25 | 9 | 34 |
| 2024 6 | 22 | 14 | 36 |
| 2024 5 | 18 | 6 | 24 |
| 2024 4 | 20 | 5 | 25 |
| 2024 3 | 37 | 8 | 45 |
| 2024 2 | 27 | 9 | 36 |
| 2024 1 | 23 | 7 | 30 |
| 2023 12 | 12 | 11 | 23 |
| 2023 11 | 30 | 10 | 40 |
| 2023 10 | 37 | 7 | 44 |
| 2023 9 | 15 | 6 | 21 |
| 2023 8 | 23 | 2 | 25 |
| 2023 7 | 38 | 16 | 54 |
| 2023 6 | 33 | 7 | 40 |
| 2023 5 | 41 | 9 | 50 |
| 2023 4 | 34 | 3 | 37 |
| 2023 3 | 45 | 5 | 50 |
| 2023 2 | 36 | 5 | 41 |
| 2022 1 | 69 | 8 | 77 |
| 2022 12 | 51 | 10 | 61 |
| 2022 11 | 50 | 10 | 60 |
| 2022 10 | 57 | 12 | 69 |
| 2022 9 | 47 | 24 | 71 |
| 2022 8 | 55 | 16 | 71 |
| 2022 7 | 38 | 13 | 51 |
| 2022 6 | 33 | 12 | 45 |
| 2022 5 | 72 | 10 | 82 |
| 2022 4 | 64 | 9 | 73 |
| 2022 3 | 115 | 10 | 125 |
| 2022 2 | 111 | 14 | 125 |
| 2021 1 | 71 | 14 | 85 |
| 2021 12 | 50 | 13 | 63 |
| 2021 11 | 84 | 16 | 100 |
| 2021 10 | 49 | 19 | 68 |
| 2021 9 | 33 | 14 | 47 |
| 2021 8 | 33 | 7 | 40 |
| 2021 7 | 28 | 6 | 34 |
| 2021 6 | 35 | 11 | 46 |
| 2021 5 | 49 | 17 | 66 |
| 2021 4 | 89 | 12 | 101 |
| 2021 3 | 58 | 16 | 74 |
| 2021 2 | 30 | 11 | 41 |
| 2020 1 | 37 | 12 | 49 |
| 2020 12 | 47 | 8 | 55 |
| 2020 11 | 42 | 9 | 51 |
| 2020 10 | 30 | 7 | 37 |
| 2020 9 | 40 | 16 | 56 |
| 2020 8 | 42 | 16 | 58 |
| 2020 7 | 29 | 8 | 37 |
| 2020 6 | 49 | 17 | 66 |
| 2020 5 | 37 | 17 | 54 |
| 2020 4 | 42 | 18 | 60 |
| 2020 3 | 47 | 19 | 66 |
| 2020 2 | 44 | 13 | 57 |
| 2020 1 | 19 | 17 | 36 |
| 2019 12 | 22 | 24 | 46 |
| 2019 11 | 37 | 19 | 56 |
| 2019 10 | 36 | 9 | 45 |
| 2019 9 | 27 | 16 | 43 |
| 2019 8 | 25 | 9 | 34 |
| 2019 7 | 42 | 21 | 63 |
| 2019 6 | 61 | 23 | 84 |
| 2019 5 | 151 | 56 | 207 |
| 2019 4 | 76 | 18 | 94 |
| 2019 3 | 13 | 8 | 21 |
| 2019 2 | 13 | 7 | 20 |
| 2019 1 | 11 | 7 | 18 |
| 2018 12 | 16 | 13 | 29 |
| 2018 11 | 17 | 20 | 37 |
| 2018 10 | 14 | 26 | 40 |
| 2018 9 | 37 | 5 | 42 |
| 2018 8 | 6 | 9 | 15 |
| 2018 7 | 10 | 0 | 10 |
| 2018 6 | 17 | 0 | 17 |
| 2018 5 | 12 | 12 | 24 |
| 2018 4 | 13 | 2 | 15 |
| 2018 3 | 5 | 1 | 6 |
| 2018 2 | 2 | 1 | 3 |
| 2018 1 | 5 | 3 | 8 |
| 2017 12 | 15 | 6 | 21 |
| 2017 11 | 12 | 5 | 17 |
| 2017 10 | 1 | 0 | 1 |
| 2016 11 | 0 | 1 | 1 |
| 2016 10 | 0 | 6 | 6 |
| 2016 9 | 0 | 6 | 6 |
| 2016 8 | 1 | 5 | 6 |
| 2016 7 | 0 | 1 | 1 |
| 2016 6 | 0 | 3 | 3 |
| 2016 5 | 0 | 3 | 3 |
| 2016 4 | 2 | 1 | 3 |
| 2016 3 | 3 | 1 | 4 |
| 2016 2 | 8 | 2 | 10 |
| 2015 1 | 9 | 1 | 10 |
| 2015 12 | 5 | 1 | 6 |
| 2015 11 | 19 | 3 | 22 |
Mostrar todo
